Cargando…

Splenic artery embolization with detachable balloons for hypersplenism

OBJECTIVE: This study was performed to investigate the efficacy of proximal splenic artery embolization using detachable balloons for patients with hypersplenism and portal hypertension. METHODS: Twelve patients diagnosed with hypersplenism with thrombocytopenia or leukocytopenia caused by portal hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Xiaoxi, Li, Tengyu, Wang, Cheng’en
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166328/
https://www.ncbi.nlm.nih.gov/pubmed/30027780
http://dx.doi.org/10.1177/0300060518786419
_version_ 1783360017899978752
author Pang, Xiaoxi
Li, Tengyu
Wang, Cheng’en
author_facet Pang, Xiaoxi
Li, Tengyu
Wang, Cheng’en
author_sort Pang, Xiaoxi
collection PubMed
description OBJECTIVE: This study was performed to investigate the efficacy of proximal splenic artery embolization using detachable balloons for patients with hypersplenism and portal hypertension. METHODS: Twelve patients diagnosed with hypersplenism with thrombocytopenia or leukocytopenia caused by portal hypertension were treated by proximal splenic artery embolization with detachable balloons and metallic fibered coils. All patients were followed for up to 6 months. Blood parameters, coagulation factors, and liver function indicators were measured. Enhanced computed tomography and abdominal ultrasonography examinations were also performed in advance to confirm the infarction area and evaluate the changes in spleen size. RESULTS: Postoperative angiography demonstrated complete embolization of the proximal splenic artery in all 12 patients. Thrombocyte and leukocyte counts rose significantly in all patients in 2 weeks and stayed significantly higher than those before embolization throughout the 6-month follow-up. The total bilirubin concentration and prothrombin activity recovered significantly and returned to normal levels 6 months later. Computed tomography revealed partial infarction and liquefaction of the splenic parenchyma in nine patients. CONCLUSIONS: Proximal splenic artery embolization using detachable balloons could be considered a safe and effective therapeutic modality in alleviating hypersplenism secondary to portal hypertension.
format Online
Article
Text
id pubmed-6166328
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61663282018-10-03 Splenic artery embolization with detachable balloons for hypersplenism Pang, Xiaoxi Li, Tengyu Wang, Cheng’en J Int Med Res Clinical Research Reports OBJECTIVE: This study was performed to investigate the efficacy of proximal splenic artery embolization using detachable balloons for patients with hypersplenism and portal hypertension. METHODS: Twelve patients diagnosed with hypersplenism with thrombocytopenia or leukocytopenia caused by portal hypertension were treated by proximal splenic artery embolization with detachable balloons and metallic fibered coils. All patients were followed for up to 6 months. Blood parameters, coagulation factors, and liver function indicators were measured. Enhanced computed tomography and abdominal ultrasonography examinations were also performed in advance to confirm the infarction area and evaluate the changes in spleen size. RESULTS: Postoperative angiography demonstrated complete embolization of the proximal splenic artery in all 12 patients. Thrombocyte and leukocyte counts rose significantly in all patients in 2 weeks and stayed significantly higher than those before embolization throughout the 6-month follow-up. The total bilirubin concentration and prothrombin activity recovered significantly and returned to normal levels 6 months later. Computed tomography revealed partial infarction and liquefaction of the splenic parenchyma in nine patients. CONCLUSIONS: Proximal splenic artery embolization using detachable balloons could be considered a safe and effective therapeutic modality in alleviating hypersplenism secondary to portal hypertension. SAGE Publications 2018-07-20 2018-10 /pmc/articles/PMC6166328/ /pubmed/30027780 http://dx.doi.org/10.1177/0300060518786419 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Research Reports
Pang, Xiaoxi
Li, Tengyu
Wang, Cheng’en
Splenic artery embolization with detachable balloons for hypersplenism
title Splenic artery embolization with detachable balloons for hypersplenism
title_full Splenic artery embolization with detachable balloons for hypersplenism
title_fullStr Splenic artery embolization with detachable balloons for hypersplenism
title_full_unstemmed Splenic artery embolization with detachable balloons for hypersplenism
title_short Splenic artery embolization with detachable balloons for hypersplenism
title_sort splenic artery embolization with detachable balloons for hypersplenism
topic Clinical Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166328/
https://www.ncbi.nlm.nih.gov/pubmed/30027780
http://dx.doi.org/10.1177/0300060518786419
work_keys_str_mv AT pangxiaoxi splenicarteryembolizationwithdetachableballoonsforhypersplenism
AT litengyu splenicarteryembolizationwithdetachableballoonsforhypersplenism
AT wangchengen splenicarteryembolizationwithdetachableballoonsforhypersplenism